Automate Your Wheel Strategy on HOLX
With Tiblio's Option Bot, you can configure your own wheel strategy including HOLX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HOLX
- Rev/Share 18.005
- Book/Share 21.5879
- PB 3.4278
- Debt/Equity 0.5209
- CurrentRatio 3.5547
- ROIC 0.0743
- MktCap 16459026868.0
- FreeCF/Share 4.3608
- PFCF 16.8258
- PE 29.7959
- Debt/Assets 0.2864
- DivYield 0
- ROE 0.1151
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | HOLX | Evercore ISI | In-line | Outperform | -- | $78 | Oct. 7, 2025 |
| Upgrade | HOLX | Argus | Hold | Buy | -- | $80 | Aug. 18, 2025 |
| Upgrade | HOLX | RBC Capital Mkts | Sector Perform | Outperform | -- | $87 | Aug. 6, 2025 |
| Upgrade | HOLX | Citigroup | Neutral | Buy | -- | $80 | July 9, 2025 |
| Reiterated | HOLX | Needham | -- | Hold | -- | -- | May 27, 2025 |
| Downgrade | HOLX | Argus | Buy | Hold | -- | -- | March 3, 2025 |
| Downgrade | HOLX | Leerink Partners | Outperform | Market Perform | $80 | $75 | Feb. 6, 2025 |
| Downgrade | HOLX | Needham | Buy | Hold | -- | -- | Feb. 3, 2025 |
| Initiation | HOLX | Wolfe Research | -- | Peer Perform | -- | -- | Dec. 13, 2024 |
| Reiterated | HOLX | Needham | -- | Buy | -- | $90 | Dec. 10, 2024 |
News
Blackstone, TPG to Buy Hologic for Up to $18.3 Billion
Published: October 21, 2025 by: WSJ
Sentiment: Positive
Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women's-health company for $76 apiece in cash.
Read More
Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal
Published: October 21, 2025 by: Reuters
Sentiment: Positive
Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in an up to $18.3 billion deal, the company said on Tuesday.
Read More
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #aquisition--Hologic to be Acquired by Blackstone and TPG for up to $79 per Share.
Read More
Billion-Dollar Buyout Buzz Boosts Medtech Stock
Published: October 20, 2025 by: Schaeffers Research
Sentiment: Positive
Shares of Hologic Inc (NASDAQ:HOLX) are up 2.4% to trade at $71.51 at last glance, earlier tapping $73.09 their highest level since early January.
Read More
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
Read More
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Read More
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.
Read More
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
Read More
How to Play HOLX Stock This Breast Cancer Awareness Month?
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
Read More
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
Read More
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Read More
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Read More
Volition Signs Co-Marketing and Services Agreement with Hologic
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral
HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ("Hologic") for the co-marketing of Volition's Nu.Q® Discover service.
Read More
Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral
HAUPPAUGE, N.Y. , Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States.
Read More
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.
Read More
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
Published: September 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.
Read More
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Hologic's Strong International Traction to Continue Despite Headwinds
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Negative
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
Read More
Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock?
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.
Read More
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.
Read More
Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Hologic, Inc. (NASDAQ:HOLX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Stephen MacMillan - Chairman, CEO & President Conference Call Participants Kallum Titchmarsh - Morgan Stanley, Research Division Michael Matson - Needham & Company, LLC, Research Division Presentation Kallum Titchmarsh Equity Analyst Okay. Thank you, everyone.
Read More
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.
Read More
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.
Read More
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Read More
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
Read More
Here's Why Hologic (HOLX) is a Strong Value Stock
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.
Read More
About Hologic, Inc. (HOLX)
- IPO Date 1990-03-01
- Website https://www.hologic.com
- Industry Medical - Instruments & Supplies
- CEO Stephen P. MacMillan
- Employees 7063